glp 1 and intracranial hypertension Novel use of GLP-1 receptor agonist therapy for pediatric idiopathic hypertension: a case report Efficacy of glucagon-like peptide-1 receptor
Description
These are frequently most pronounced during early use and dose escalation phases, and they often improve over time
Same 3-minute convenience, different format
doi:10.1007/s10571-004-1374-y 26
CNBC's Jim Cramer on Wednesday explained how GLP-1 drugs are influencing market action
Int J Obes (Lond) 2014;38:689697
Note: Leftovers can be reheated, but its surprisingly delicious served cold
